3-day culminating event was conducted in Beirut, Lebanon in the frame of “Building Institutional Capacity for Health Policy and Systems Research and Delivery science (BIRD) in six WHO Regions” program. The meeting aimed to reflect on achievements and learnings and plan for the future of the Mentorship Program.
The Inclusive Development Hub of USAID’s Bureau for Development, Democracy, and Innovation has partnered with the Accelerator to support countries in strengthening and integrating rehabilitation services in the health systems.
The project will achieve the aim through two objectives: Investigate the recent reforms in the pharmaceutical sector and their impact on the access to medicines for Georgia citizens.
Promote civic engagement and enhance the role of civic society in advocacy towards sustainable policy solutions in access to affordable medicines.
Globally, the COVID-19 vaccination started at the end of 2020 and continues at a different paces in various countries. As of December 7 2021, 8 billion doses of vaccine have been administered worldwide, and 45% of the world’s population has been fully vaccinated.
The study will reveal the systemic weaknesses that have to be addressed by the Government by using, the public finance management (PFM), in Health Toolkit Version 2.7, developed by the Bank in October 2019.
The 12-month duration project aims to assess the risks of imported TB infection spread by foreign visitors and propose a set of mechanisms for risk prevention based on international experience
As part of the World Bank’s support to improving health service delivery in the country and efforts to explore prospects of harnessing domestic resources for health, Curatio International Foundation conducts fiscal space analysis in collaboration with the Government of Georgia to maximize the achievement of the health sector objectives within the overall macroeconomic and fiscal realities of the country
TB response during Covid-19
დოკუმენტის მიზანია მედიკამენტების ფასების რეგულირების ერთერთი ფართოდ გავრცელებული მექანიზმის – გარე რეფერენტული ფასწარმოქმნის (გრფ) პოლიტიკის შედეგების მიმოხილვა მედიკამენტებზე ხელმისაწვდომობის გაუმჯობესების კუთხით